# ENB Financial Corp: financial statements, quarterly

ENBP · OTC · CIK 1437479 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/enbp.md) · [Financials](/companies/enbp/financials.md) · [Filings](/companies/enbp/filings.md) · [Insiders](/companies/enbp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/enbp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [6,679](/filings/0001174947-23-001397.md) | [7,822 d](/filings/0001174947-24-000388.md) | [8,199](/filings/0001174947-24-000739.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [771](/filings/0001174947-24-001262.md) | [1,004 d](/filings/0001174947-25-000372.md) | [827](/filings/0001174947-25-000756.md) | [920](/filings/0002077096-25-000012.md) | [752](/filings/0001174947-25-001388.md) | [809 d](/filings/0001174947-26-000410.md) | [982](/filings/0001174947-26-000608.md) | [1,380](/filings/0001174947-26-000805.md) | [1,419](/filings/0001174947-25-001388.md) | [1,395 d](/filings/0001174947-26-000410.md) | [1,022](/filings/0001174947-26-000608.md) | [1,335](/filings/0001174947-26-000805.md) |
| Net income | $k | [3,613](/filings/0001174947-24-001262.md) | [4,524 d](/filings/0001174947-25-000372.md) | [3,941](/filings/0001174947-25-001388.md) | [4,314](/filings/0001174947-25-001388.md) | [3,336](/filings/0001174947-25-001388.md) | [3,726 d](/filings/0001174947-26-000410.md) | [4,316](/filings/0001174947-26-000805.md) | [5,810](/filings/0001174947-26-000805.md) | [5,919](/filings/0001174947-25-001388.md) | [5,514 d](/filings/0001174947-26-000410.md) | [4,024](/filings/0001174947-26-000805.md) | [5,704](/filings/0001174947-26-000805.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [0.76](/filings/0001174947-26-000608.md) | [1.02](/filings/0001174947-26-000805.md) | not reported | not reported | [0.71](/filings/0001174947-26-000608.md) | [1.00](/filings/0001174947-26-000805.md) |
| Basic EPS | $ per share | [0.64](/filings/0001174947-24-001262.md) | not reported | [0.70](/filings/0001174947-25-000756.md) | [0.76](/filings/0002077096-25-000012.md) | [0.59](/filings/0001174947-25-001388.md) | not reported | [0.76](/filings/0001174947-26-000608.md) | [1.02](/filings/0001174947-26-000805.md) | [1.04](/filings/0001174947-25-001388.md) | not reported | [0.71](/filings/0001174947-26-000608.md) | [1.00](/filings/0001174947-26-000805.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.8](/filings/0001174947-24-001262.md) | [89.0](/filings/0001174947-25-000372.md) | [67.9](/filings/0001174947-25-000756.md) | [107](/filings/0002077096-25-000012.md) | [67.7](/filings/0001174947-25-001388.md) | [68.9](/filings/0001174947-26-000410.md) | [78.7](/filings/0001174947-26-000608.md) | [65.3](/filings/0001174947-26-000805.md) | [48.4](/filings/0001174947-25-001388.md) | [60.6](/filings/0001174947-26-000805.md) | [89.5](/filings/0001174947-26-000608.md) | [37.1](/filings/0001174947-26-000805.md) |
| Total assets | $m | [1,909](/filings/0001174947-24-001262.md) | [2,001](/filings/0001174947-25-000372.md) | [1,992](/filings/0001174947-25-000756.md) | [2,025](/filings/0002077096-25-000012.md) | [2,092](/filings/0001174947-25-001388.md) | [2,220](/filings/0001174947-26-000410.md) | [2,221](/filings/0001174947-26-000608.md) | [2,226](/filings/0001174947-26-000805.md) | [2,223](/filings/0001174947-25-001388.md) | [2,258](/filings/0001174947-26-000805.md) | [2,424](/filings/0001174947-26-000608.md) | [2,391](/filings/0001174947-26-000805.md) |
| Total liabilities | $m | [1,811](/filings/0001174947-24-001262.md) | [1,881](/filings/0001174947-25-000372.md) | [1,870](/filings/0001174947-25-000756.md) | [1,899](/filings/0002077096-25-000012.md) | [1,957](/filings/0001174947-25-001388.md) | [2,089](/filings/0001174947-26-000410.md) | [2,086](/filings/0001174947-26-000608.md) | [2,086](/filings/0001174947-26-000805.md) | [2,071](/filings/0001174947-25-001388.md) | [2,097](/filings/0001174947-26-000805.md) | [2,261](/filings/0001174947-26-000608.md) | [2,220](/filings/0001174947-26-000805.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [60.0](/filings/0001174947-26-000410.md) | [60.0](/filings/0001174947-26-000608.md) | [60.0](/filings/0001174947-26-000805.md) | [60.0](/filings/0001174947-25-001388.md) | [60.0](/filings/0001174947-26-000805.md) | [60.0](/filings/0001174947-26-000608.md) | [76.0](/filings/0001174947-26-000805.md) |
| Shareholders' equity | $m | [97.5](/filings/0001174947-24-001262.md) | [120](/filings/0001174947-26-000410.md) | [122](/filings/0001174947-25-001388.md) | [126](/filings/0001174947-25-001388.md) | [135](/filings/0001174947-25-001388.md) | [131](/filings/0001174947-26-000805.md) | [135](/filings/0001174947-26-000805.md) | [139](/filings/0001174947-26-000805.md) | [152](/filings/0001174947-25-001388.md) | [161](/filings/0001174947-26-000805.md) | [163](/filings/0001174947-26-000805.md) | [172](/filings/0001174947-26-000805.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.7 d](/filings/0001174947-24-001262.md) | [7.3 d](/filings/0001174947-25-000372.md) | [1.4](/filings/0001174947-25-000756.md) | [6.2 d](/filings/0002077096-25-000012.md) | [5.2 d](/filings/0001174947-25-001388.md) | [3.0 d](/filings/0001174947-26-000410.md) | [4.1](/filings/0001174947-26-000608.md) | [6.2 d](/filings/0001174947-26-000805.md) | [10.0 d](/filings/0001174947-25-001388.md) | [4.7 d](/filings/0001174947-26-000410.md) | [3.6](/filings/0001174947-26-000608.md) | [6.5 d](/filings/0001174947-26-000805.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001174947-24-001262.md) | [0.4 d](/filings/0001174947-25-000372.md) | [1.7](/filings/0001174947-25-000756.md) | [0.1 d](/filings/0002077096-25-000012.md) | [2.3 d](/filings/0001174947-25-001388.md) | [0.2 d](/filings/0001174947-26-000410.md) | [1.0](/filings/0001174947-26-000608.md) | [1.5 d](/filings/0001174947-26-000805.md) | [2.1 d](/filings/0001174947-25-001388.md) | [1.3 d](/filings/0001174947-26-000410.md) | [0.8](/filings/0001174947-26-000608.md) | [0.9 d](/filings/0001174947-26-000805.md) |
| Dividends paid | $m | [1.0 d](/filings/0001174947-24-001262.md) | [1.0 d](/filings/0001174947-25-000372.md) | [1.0](/filings/0001174947-25-000756.md) | [1.0 d](/filings/0002077096-25-000012.md) | [1.0 d](/filings/0001174947-25-001388.md) | [1.0 d](/filings/0001174947-26-000410.md) | [1.0](/filings/0001174947-26-000608.md) | [1.0 d](/filings/0001174947-26-000805.md) | [1.0 d](/filings/0001174947-25-001388.md) | [1.0 d](/filings/0001174947-26-000410.md) | [1.0](/filings/0001174947-26-000608.md) | [1.0 d](/filings/0001174947-26-000805.md) |
| Share repurchases | $m | [0.1 d](/filings/0001174947-24-001262.md) | [0.1 d](/filings/0001174947-25-000372.md) | [0.2](/filings/0001174947-25-000756.md) | [0.2 d](/filings/0002077096-25-000012.md) | [0.9 d](/filings/0001174947-25-001388.md) | [0.0 d](/filings/0001174947-26-000410.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,658](/filings/0001174947-26-000608.md) | [5,673](/filings/0001174947-26-000805.md) | [5,696](/filings/0001174947-26-000608.md) | [5,706](/filings/0001174947-26-000805.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,714,719 at 2026-08-01, from the cover of the [10-Q filed 2026-08-14](/filings/0001174947-26-000805.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.